• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Artificial intelligence, drug repurposing and peer review.

作者信息

Levin Jeremy M, Oprea Tudor I, Davidovich Sagie, Clozel Thomas, Overington John P, Vanhaelen Quentin, Cantor Charles R, Bischof Evelyne, Zhavoronkov Alex

机构信息

Ovid Therapeutics, Inc, New York, NY, USA.

Biotechnology Innovation Organization (BIO), Washington, DC, USA.

出版信息

Nat Biotechnol. 2020 Oct;38(10):1127-1131. doi: 10.1038/s41587-020-0686-x.

DOI:10.1038/s41587-020-0686-x
PMID:32929264
Abstract
摘要

相似文献

1
Artificial intelligence, drug repurposing and peer review.人工智能、药物重新利用与同行评审。
Nat Biotechnol. 2020 Oct;38(10):1127-1131. doi: 10.1038/s41587-020-0686-x.
2
How has artificial intelligence impacted COVID-19 drug repurposing and what lessons have we learned?人工智能如何影响了新冠病毒药物的重新利用，我们从中吸取了哪些教训？
Expert Opin Drug Discov. 2022 Oct;17(10):1061-1065. doi: 10.1080/17460441.2022.2128333. Epub 2022 Sep 26.
3
Multi-Omics and Artificial Intelligence-Guided Drug Repositioning: Prospects, Challenges, and Lessons Learned from COVID-19.多组学和人工智能指导的药物重定位：从 COVID-19 中得到的前景、挑战和经验教训。
OMICS. 2022 Jul;26(7):361-371. doi: 10.1089/omi.2022.0068. Epub 2022 Jun 28.
4
Recent advances in drug repurposing using machine learning.基于机器学习的药物重定位的最新进展。
Curr Opin Chem Biol. 2021 Dec;65:74-84. doi: 10.1016/j.cbpa.2021.06.001. Epub 2021 Jul 16.
5
Structure-based drug repurposing: Traditional and advanced AI/ML-aided methods.基于结构的药物再利用：传统和先进的人工智能/机器学习辅助方法。
Drug Discov Today. 2022 Jul;27(7):1847-1861. doi: 10.1016/j.drudis.2022.03.006. Epub 2022 Mar 14.
6
A comprehensive review of artificial intelligence and network based approaches to drug repurposing in Covid-19.人工智能和基于网络的方法在新冠病毒药物再利用中的综合综述
Biomed Pharmacother. 2022 Sep;153:113350. doi: 10.1016/j.biopha.2022.113350. Epub 2022 Jun 28.
7
A survey of current trends in computational drug repositioning.计算药物重新定位的当前趋势调查。
Brief Bioinform. 2016 Jan;17(1):2-12. doi: 10.1093/bib/bbv020. Epub 2015 Mar 31.
8
Artificial intelligence, machine learning, and drug repurposing in cancer.人工智能、机器学习和癌症药物再利用。
Expert Opin Drug Discov. 2021 Sep;16(9):977-989. doi: 10.1080/17460441.2021.1883585. Epub 2021 Feb 12.
9
COVID-19 and the Drug Repurposing Tsunami.新冠疫情与药物重新利用热潮
Assay Drug Dev Technol. 2020 Jul;18(5):211-214. doi: 10.1089/adt.2020.996. Epub 2020 Jun 18.
10
An Analytical Review of Computational Drug Repurposing.计算药物再利用的分析综述。
IEEE/ACM Trans Comput Biol Bioinform. 2021 Mar-Apr;18(2):472-488. doi: 10.1109/TCBB.2019.2933825. Epub 2021 Apr 6.

引用本文的文献

1
Amphetamine use and Parkinson's disease: integration of artificial intelligence prediction, clinical corroboration, and mechanism of action analyses.安非他明使用与帕金森病：人工智能预测、临床确证及作用机制分析的整合
PLoS One. 2025 May 20;20(5):e0323761. doi: 10.1371/journal.pone.0323761. eCollection 2025.
2
Antimicrobial Peptides towards Clinical Application-A Long History to Be Concluded.抗菌肽迈向临床应用——漫长的历史即将结束。
Int J Mol Sci. 2024 Apr 29;25(9):4870. doi: 10.3390/ijms25094870.
3
Trends in orphan medicinal products approvals in the European Union between 2010-2022.

本文引用的文献

1
[A pilot study of hydroxychloroquine in treatment of patients with moderate COVID-19].羟氯喹治疗中度新型冠状病毒肺炎患者的一项试点研究
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020 May 25;49(2):215-219. doi: 10.3785/j.issn.1008-9292.2020.03.03.
2
BioBERT: a pre-trained biomedical language representation model for biomedical text mining.BioBERT：一种用于生物医学文本挖掘的预训练生物医学语言表示模型。
Bioinformatics. 2020 Feb 15;36(4):1234-1240. doi: 10.1093/bioinformatics/btz682.
2010-2022 年期间欧盟孤儿药批准的趋势。
Orphanet J Rare Dis. 2024 Feb 27;19(1):91. doi: 10.1186/s13023-024-03095-z.
4
Unraveling viral drug targets: a deep learning-based approach for the identification of potential binding sites.解析病毒药物靶点：基于深度学习的潜在结合位点鉴定方法。
Brief Bioinform. 2023 Nov 22;25(1). doi: 10.1093/bib/bbad459.
5
A review of SARS-CoV-2 drug repurposing: databases and machine learning models.新型冠状病毒2型药物重新利用综述：数据库与机器学习模型
Front Pharmacol. 2023 Aug 4;14:1182465. doi: 10.3389/fphar.2023.1182465. eCollection 2023.
6
Drug repurposing for reducing the risk of cataract extraction in patients with diabetes mellitus: integration of artificial intelligence-based drug prediction and clinical corroboration.药物再利用以降低糖尿病患者白内障摘除风险：基于人工智能的药物预测与临床验证的整合
Front Pharmacol. 2023 May 18;14:1181711. doi: 10.3389/fphar.2023.1181711. eCollection 2023.
7
Emerging Treatment Approaches for COVID-19 Infection: A Critical Review.新型冠状病毒肺炎感染的新兴治疗方法：批判性综述
Curr Mol Med. 2024;24(4):435-448. doi: 10.2174/1566524023666230417112543.
8
Intelligent De Novo Design of Novel Antimicrobial Peptides against Antibiotic-Resistant Bacteria Strains.智能从头设计新型抗菌肽对抗抗生素耐药菌。
Int J Mol Sci. 2023 Apr 5;24(7):6788. doi: 10.3390/ijms24076788.
9
Application of the PHENotype SIMulator for rapid identification of potential candidates in effective COVID-19 drug repurposing.PHENotype模拟器在快速识别新冠病毒有效药物重新利用潜在候选药物中的应用。
Heliyon. 2023 Mar;9(3):e14115. doi: 10.1016/j.heliyon.2023.e14115. Epub 2023 Mar 6.
10
DrugCentral 2023 extends human clinical data and integrates veterinary drugs.DrugCentral 2023 扩展了人类临床数据并整合了兽药。
Nucleic Acids Res. 2023 Jan 6;51(D1):D1276-D1287. doi: 10.1093/nar/gkac1085.